A Trial of C13-CAC Breath Test in PPI Resistant GERD Patients

Clinical trial NCT03284177 · COMPLETED

Trial details

NCT number: NCT03284177
Sponsor: Otsuka Pharmaceutical Co., Ltd.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Gastroesophageal Reflux Disease

Start date: 2017-10-31
Primary completion: 2018-12-04
Enrollment: 55

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.